EpiBiome
EpiBiome is a microbiome precision engineering biotechnology company that employs a genomics approach to develop therapies to control and treat microbial infections..
Launch date
Market cap
-
Enterprise valuation
€22—33m (Dealroom.co estimates Feb 2016.)
South San Francisco California (HQ)
Financials
Estimates*
USD | 2018 | 2019 |
---|---|---|
Revenues | 3.3m | 4.3m |
% growth | - | 30 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $100k | Convertible | |
$6.0m | Series A | ||
$1.0m | Debt | ||
N/A | N/A | Early VC | |
Total Funding | €5.5m |
Related Content
Recent News about EpiBiome
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.